CONSOLIDATED BALANCE SHEETS (UNAUDITED) (EUR €) In Thousands, unless otherwise specified	Jun. 30, 2012	Dec. 31, 2011
Current Assets
Cash	€ 659	€ 382
Receivable other	57	61
Prepaid expenses	51	54
Total current assets	767	497
Property and equipment, net of accumulated depreciation of E257 at June 30, 2012 and E239 at December 31, 2011	32	49
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	9,736	9,483
Current Liabilities
Accounts payable	830	1,025
Taxes and social costs payable	20	2
Current portion of notes payable to related Parties	6,616	5,711
Total current liabilities	7,466	6,738
Convertible notes payable to related parties, less current portion	26,219	25,331
Acquisition-related contingent consideration	6,291	5,753
Total liabilities	39,976	37,822
Shareholders' Equity (Deficit)
Common stock, U.S. $.01 par value; 495,000,000 shares authorized; issued 295,318,813 at June 30, 2012 and 276,017,339 at December 31, 2011	2,468	2,322
Preferred stock, U.S. $.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	33,779	32,732
Deficit accumulated during the development stage	(67,149)	(64,057)
Accumulated other comprehensive income	662	664
Total shareholders' equity (deficit)	(30,240)	(28,339)
Total liabilities and shareholders' equity (deficit)	€ 9,736	€ 9,483